State of New Jersey Common Pension Fund D decreased its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 42,831 shares of the company’s stock after selling 651 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Clorox were worth $6,956,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. State Street Corp lifted its position in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC increased its stake in Clorox by 46,877.8% during the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC increased its stake in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the last quarter. Stifel Financial Corp increased its stake in Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after acquiring an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp increased its stake in Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after acquiring an additional 31,510 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analyst Ratings Changes
CLX has been the subject of several recent analyst reports. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. raised their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Four research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, Clorox has an average rating of “Hold” and an average price target of $158.21.
Clorox Trading Up 0.1 %
CLX opened at $148.11 on Wednesday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market capitalization of $18.33 billion, a price-to-earnings ratio of 40.47, a PEG ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.62. The business has a fifty day moving average price of $158.78 and a 200 day moving average price of $159.71.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business posted $2.16 earnings per share. Sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- Where Do I Find 52-Week Highs and Lows?
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Capture the Benefits of Dividend Increases
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.